Supporting start-up, small and medium companies with innovative development programs. Focusing on early phase (bench to phase III) development of Cell and Gene based Therapies, Biosimilars and Biotech-products.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
